Dr Bussel discusses the prolonged responses to TPO-R agonists at a symposium on idiopathic thrombocytopenic purpura at EHA 2014.
GlaxoSmithKline fully provided for the costs of this symposium, honoraria for the Chairs & speakers and provided input into the symposium agenda/content.